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Objective: To examine the reproducibility, responsiveness 
and concurrent validity of the six-minute walk test (6MWT) 
when tested outdoors in patients’ own neighbourhoods using 
a global positioning system (GPS) or a measuring wheel.
Methods: A total of 27 chronic stroke patients, discharged 
to their own homes, were tested twice, within 5 consecutive 
days. The 6MWT was conducted using a GPS and an meas-
uring wheel simultaneously to determine walking distance. 
Reproducibility was determined as test-retest reliability 
and agreement, using the intraclass correlation coefficient, 
standard error of measurement and Bland & Altman plots. 
Responsiveness was expressed as the smallest real difference 
and visualized in Bland & Altman plots. Pearson’s corre-
lation coefficient (r) was used to study concurrent validity 
between the GPS and measuring wheel.
Results: Intraclass correlation coefficiens were 0.96 for the 
GPS and 0.98 for the measuring wheel, and standard error 
of measurement scores were 11.9 m for the measuring wheel 
and 18.1 m for the GPS, resulting in smallest real differences 
of 33.0 m and 50.2 m, respectively. Concurrent validity was 
strong (r = 0.99).
Conclusion: These results indicate that the outdoor 6MWT 
using a GPS or measuring wheel is reproducible, responsive 
and concurrently valid. This suggests that therapists work-
ing in the community can use the outdoor 6MWT as a reli-
able, responsive and valid test.
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INTRODUCTION
Although several prospective cohort studies have shown that 
approximately 85% of patients who have had a stroke regain 
gait by 6 months post-stroke (1, 2), approximately 20% of all 
stroke survivors show significant deterioration in mobility 
status between 1 and 3 years after stroke (3). Patients’ walking 
competency after stroke is often assessed with the six-minute 
walk test (6MWT), which has been recommended (4) as a reli-
able (5, 6), responsive (7) and valid measure (6). The 6MWT 
is a uni-dimensional measure that assesses walking endurance 
when used with a standardized protocol (8). Research has shown 
that timed walk tests conducted over short distances, such as the 
10-m test, tend to overestimate performance on the 6MWT and 
should complement, but not replace, the 6MWT (9). 
Conducting the 6MWT requires appropriate indoor testing 
facilities, such as a gym or a large corridor in a clinical setting. 
This means that patients who are treated by physical or occu-
pational therapists at home have to be transported to a gym or 
outpatient clinic for the appropriate test facilities. To the patient, 
the transport is not only burdensome, but also expensive. The 
challenge for the healthcare system is to apply rehabilitation 
services preferably in the patient’s own environment, and thus 
to reduce the costs and burden of travel for patients with stroke. 
As a consequence, the 6MWT needs to be conducted in a valid 
and reproducible manner in the patient’s own neighbourhood. 
Thus far, only a few studies have included stroke survivors 
performing the 6MWT in various indoor and outdoor environ-
ments, such as a suburban street (10, 11), shopping mall (10, 
11) and a walkway in a quiet garden (12). However, none of 
these studies assessed the use of the 6MWT in patients’ own 
neighbourhood using a global positioning system (GPS) as 
a potentially innovative tool to determine outdoor walking 
distance. 
The first aim of the present study was to investigate the repro-
ducibility and responsiveness of the 6MWT when tested outdoors 
in the patients’ own neighbourhoods by using a GPS or a measur-
ing wheel (MW). The second aim was to investigate the concur-
rent validity of conducting the 6MWT in the stroke survivors’ 
own neighbourhoods using a GPS compared with an MW. 
METHODS
Participants 
All participants for the present study were recruited from the FIT-
Stroke trial, which is a randomized controlled trial conducted in 9 
rehabilitation centres in the Netherlands (13). The FIT-Stroke protocol 
has been approved by the medical ethics committees of the University 
Medical Centre Utrecht and all the participating rehabilitation centres, 
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and is registered in the Dutch Trial Register (NTR1534). Eligible pa-
tients met the following inclusion criteria: (i) verified stroke according 
to the World Health Organization (WHO) (2001) definition; (ii) ability 
to walk a minimum of 10 m without physical assistance from a therapist 
(i.e. patient may require verbal supervision or stand-by help from a 
person, and may use an aid or orthotics, but should be classified as 
Functional Ambulation Category ≥ 3); (iii) discharged home from an 
inpatient rehabilitation centre; (iv) informed consent and willingness to 
perform two 6MWTs outdoors at the final assessment of the FIT-Stroke 
trial (i.e. 24 weeks after randomization). Participants were excluded if 
they: (i) had severe cognitive deficits as evaluated by the Mini-Mental 
State Examination (< 24 points); (ii) were unable to communicate (i.e. 
< 4 points on the Utrechts Communicatie Onderzoek; UCO (14)) or 
(3) lived more than 30 km from the rehabilitation centre. 
Study design
Each recruited participant was invited to perform two 6MWTs in their 
own neighbourhood. These tests were conducted with an interval of 
maxi mally 5 days. Four trained assessors performed the 6MWTs accord-
ing to a standardized protocol, using Google Earth (GE) to find a ap-
propriate walking course in the patients’ own neighbourhood, and using 
GPS and a MW to determine the walking distance attained in 6 min. 
Testing six-minute walk test in patients’ own neighbourhoods
All assessors were instructed in advance as to how to find a safe and 
appropriate walking course in the patients’ neighbourhoods using 
Google Earth. Each assessor was instructed to select an appropriate 
course, such as a flat pavement, preferably with a length of 30 m, 
without the need to cross streets. In addition, assessors were only 
allowed to conduct the 6MWT when the weather was dry. The same 
course had to be used for the second 6MWT and patients were in-
structed to use the same shoes during both measurements.
After visually checking the walking course for appropriateness, each 
assessor used a handheld GPS as well as a hand-driven MW to establish 
the distance covered during the 6MWTs. The GPS used was a Garmin 
GPSMAP 60Cx expressing horizontal accuracy by twice the distance 
root mean squared (2DRMS). The 2DRMS (95%) is 100 metres. The 
assessors simultaneously pushed a MW (Nedo 703 112) while conducting 
the 6MWT. The MW had a rubber tyre and a digital counter with a known 
accuracy of 99.8% (1 cm error) when tested over a distance of 50 m. 
A stopwatch was used to measure the time taken during the 6MWT.
The 6MWTs in the patients’ own neighbourhoods were conducted 
following the standardized indoor 6MWT protocol by Guyatt et al. (6). 
This protocol is known to be a reliable and valid method to measure 
walking endurance in patients with a compromised walking ability 
(15, 16), including patients with hemiplegic gait (17–19). During the 
6MWTs, all patients received standardized instructions to walk as far as 
possible at their comfortable pace for 6 min. Running was not allowed. 
After each minute, the assessor delivered one of a predetermined set 
of encouraging phrases, such as “You’re doing well” or “keep up the 
good work”. At the end of the test the assessor called “Stop”, and the 
distance walked was recorded. For safety reasons, the assessor walked 
with the patient to provide the necessary physical assistance if any was 
needed. To avoid pacing, the assessor walked behind the participant 
while measuring the distance covered with the GPS and MW. 
Reproducibility
Test-retest reliability. Test-retest reliability was defined as the degree 
to which the measurement error corresponds to the variability between 
the participants who did the 6MWTs (20). The test-retest reliability of 
the 6MWT was examined using the intraclass correlation coefficiens 
(ICC), a two-way random effects model with absolute agreement. This 
ICCagreement assumes that observers and patients form a random sample 
of a population and is calculated by the following formula: 
ICCagreement = ((BMS-EMS)/k) / ((BMS-EMS/k) + (OMS-EMS/n) 
+ EMS) 
where BMS (between-subjects mean square) is the variability be-
tween participants, EMS (error mean square) the residual mean square, 
OMS (observation mean square) the variability between assessors, k 
the number of assessors and n the number of participants (20). The 
variables BMS, EMS and OMS were derived from an analysis of 
variance (ANOVA) table. ICC values less than 0.4 were classified as 
poor reliability, between 0.4 and 0.75 as fair reliability and greater 
than 0.75 as excellent reliability (21). 
Agreement. Agreement concerns the absolute measurement error, i.e. 
the degree of correspondence between the distances walked during 
the first and second 6MWTs (22). The standard error of measurement 
for agreement (SEMagreement) represented this measurement error as 
absolute values. SEMagreement was calculated as follows:
SEMagreement=√((OMS-EMS/n) + EMS) 
Systematic differences between the two 6MWT distances measured 
by GPS or MW were investigated with Bland & Altman analysis (23, 
24), by plotting the mean difference found between the two consecu-
tive assessments against the standard deviation (SD) of the calculated 
difference (23), while the limits of agreement were calculated as the 
mean difference ± 1.96 times the SD of the differences.
Responsiveness
Bland & Altman plots were used to visualize systematic variations around 
the zero line (25). If Bland & Altman analyses indicate no large systematic 
differences with regard to the limits of agreement, the smallest real differ-
ence (SRD) indicates a real (clinical) improvement or deterioration for a 
single individual on the basis of the limits of agreement, which were based 
on the standard error of measurement (SEM) for agreement (26):
SRD = 1.96 * √2 * SEM
Concurrent validity
The concurrent validity of the GPS and MW for measuring the 6MWT 
was determined by calculating a correlation coefficient. If visual in-
spection of the outcomes of the 6MWTs revealed a normal distribution, 
we used Pearson’s correlation coefficient, otherwise a Spearman’s 
rho. In accordance with Cohen’s classification, a strong association 
was defined if the coefficient exceeded 0.70, whereas a coefficient 
between 0.30 and 0.70 was classified as moderate to substantial and 
a coefficient below 0.30 as a weak association (27).
All data were analysed using SPSS (version 16.0), while all statisti-
cal tests were applied two-tailed with a critical p-value of < 0.05.
Table I. Participant characteristics (n=27)
variable
Female gender, n (%) 6 (22)
Age, years, mean (SD) 60.7 (10.9)
Height, cm, mean (SD) 177 (9)
Weight, kg, mean (SD) 81 (16)
First stroke, n (%) 23 (85)
Previous stroke, n (%) 4 (15)
Days from stroke to 1st assessment, mean (SD) 266 (38.0)
Days between 1st and 2nd assessments, mean (SD) 1.5 (1.3)
Type of stroke, ischaemic/haemorrhagic strokes, n 24/3
Hemisphere of stroke, lACI/PACI/TACI/POCI, n 10/11/0/3
Hemiparetic side, left/right/bilateral, n 12/13/2
UCO score, 4/5, n 3/24
FAC score, 3/4/5, n 1/3/23
lCT score, left/right/none, n 1/3/23
Walking device, cane/quad cane/walker, n 6/1/0
AFO/orthotic shoe, n 6/1
lACI: lacunar infarcts; PACI: partial anterior circulation infarcts; TACI: 
total anterior circulation infarcts; POCI: posterior circulation infarcts; 
UCO: Utrechts Communicatie Onderzoek; FAC: functional ambulation 
categories; lCT: letter cancellation task, having 2 omissions or more 
on 1 side compared with the other side; AFO: ankle-foot orthotics; SD: 
standard deviation.
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RESUlTS
The main characteristics of the 27 individuals (21 men, 6 
women) included in the study are presented in Table I. The 
age of the participants ranged from 35 to 76 years, while the 
mean interval between the stroke and the first assessment of 
the 6MWT was 266 days (SD 38.0 days). Measurements with 
GPS yielded mean distances for the first and second 6MWTs of 
408 m (SD 132 m) and 417 m (SD 139 metres), respectively. 
Measurements with the MW yielded mean distances of 413 m 
(SD = 127 m) and 422 m (SD 132 m) for the first and second 
assessments, respectively (Table II). 
Reproducibility
Table III shows the test-retest reliability, agreement and re-
sponsiveness of the 6MWTs using GPS or MW. Assessment of 
the test-retest reliability between the first and second 6MWTs 
yielded ICCagreement scores of 0.96 and 0.98, respectively. The 
SEMagreement for GPS was found to be 18.1 metres, compared 
with 11.9 metres for MW. The Bland & Altman plots (Fig. 1) 
showed mean differences between the 6MWTs to be above 
zero (d = 9 m), with limits of agreement ranging from –4.7 to 
22.7 metres when using GPS (Fig. 1a), and from –0.8 to 18.8 
m when using the MW (Fig. 1b). The SRD was 50.2 m for GPS 
and 33.0 m for the MW. 
Concurrent validity
visual inspection of histograms of the 6MWTs showed normal 
distributions. Pearson’s correlation coefficient for the first 
6MWTs using GPS vs the first 6MWTs using MW was 0.98 
(p < 0.00), while the second 6MWT using GPS vs MW yielded 
an r = 0.99 (p < 0.00). 
DISCUSSION
The present study showed that conducting the 6MWT over a 
predefined course selected with Google Earth, while using GPS 
or a measuring wheel (MW) to determine the distance walked, 
is a feasible, highly reproducible and responsive method to as-
sess walking endurance in stroke patients’ own neighbourhood. 
We also found a strong association between the values of the 
6MWT protocol measured by GPS and MW during the outdoor 
6MWTs. Re-testing yielded a non-significant 9-m increment in 
walking distance (on top of a total of over 400 m) when using 
the GPS and a significant 9-m increment when using the MW. 
This small increase in both measures may reflect a practice ef-
fect (7, 19), but in agreement with a previous study by Salbach 
et al. (16), the mean differences between the two consecutive 
6MWTs were close to zero, suggesting that this learning effect is 
Table II. 6MWT outcome (n = 27)
variable Mean (SD) Range
GPS 1st measurement, m 408 (132) 133–700
GPS 2nd measurement, m 417 (139) 127–695
MW 1st measurement, m 413 (127) 129–664
MW 2nd measurement, m 422 (132) 125–668
6MWT: six-minute walk test; GPS: global positioning system; MW: 
measuring wheel; SD: standard deviation.
Table III. Test-retest reliability, agreement and responsiveness (n = 27)
variable ICC (95% CI) SEM SRD p
GPS 6MWT 1st vs  
GPS 6MWT 2nd 
0.96 (0.96–0.98) 18.1 50.2 0.06
MW 6MWT 1st vs  
MW 6MWT 2nd 
0.98 (0.98–1.00) 11.9 33.0 0.00
GPS: global positioning system; MW: measuring wheel; 6MWT: six-
minute walk test; ICC: intraclass correlation coefficient for agreement; 
CI: confidence interval; SEM: standard error of measurement; SRD: 
smallest real difference.
Fig. 1. (a) 1st six-minute walk test (6MWT) vs 2nd 6MWT measured by global positioning system (GPS). (b) 1st 6MWT vs 2nd 6MWT 
measured by measuring wheel (MW).
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almost negligible. The fact that the 9-m increment found in the 
second 6MWT using the MW was significant can be explained 
by the smaller measurement error and higher responsiveness of 
the MW when compared with the GPS. 
Based on found measurement error on the 6MWT indoors, 
Fulk et al. (5) described a minimum clinically important differ-
ence of 54.1 m. This value is higher than the SRDs calculated 
in the present study, which were 33.0 m for the MW and 50.2 
m for the GPS system, respectively. This finding suggests that 
outdoor testing can be performed within the accepted limits 
of error for a 6MWT and that the method is able to measure a 
meaningful effect for individuals participating in community-
based rehabilitation programmes. 
Despite the higher responsiveness of the hand-driven MW 
compared with GPS in the present study, all assessors preferred 
the GPS to the MW because of its smaller size and the fact 
that it allowed the therapists to keep their own hands free by 
attaching the GPS device to the patient’s belt or their own.
Conducting the 6MWT outdoors is subject to some limita-
tions. First, weather conditions have to be dry and calm. In 
addition, the assessors had to select outdoor walking courses 
that appeared on Google Earth to be smooth and horizontal, 
without crossing roads. Finally, 4 patients refused to participate 
in an outdoor test, as they stated that they would feel embar-
rassed if they met their neighbours. 
The present study had some limitations. First, we selected 
a relatively small sample of our stroke patients who had been 
discharged home, so our findings may not be generalizable 
to people with stroke who do not meet the eligibility criteria 
for this study. Secondly, the MW is more accurate than the 
GPS used in the study. However, more accurate types of GPS 
are now available, and future improvements in the satellite 
system will be accompanied by further improvements in the 
accuracy of location and time. Thirdly, we used a conservative 
approach in testing the reliability and responsiveness of the 
GPS or MW system, by selecting 4 independent assessors and 
using a random model to calculate ICCs. This suggests that our 
results may be an underestimation. In addition, it should be 
taken into account that the time between the two consecutive 
measurements was relatively short. 
In conclusion, the present study has yielded useful data on 
the reproducibility and validity of conducting the 6MWT in 
patients’ own home environments using GPS. In our opinion 
these results are generalizable to other settings, acknowledging 
that the GPS (like other navigator systems) is robust amongst 
tall buildings and in changing environments.
The main finding is that conducting the 6MWT in the 
patients’ own neighbourhood is highly reproducible and 
responsive. Outdoor 6MWTs, using either GPS or MW, can 
be recommended for stroke patients to evaluate their walking 
endurance in their own neighbourhood. 
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